Literature DB >> 18946602

Primary oesophageal Ki (CD30)-positive ALK+ anaplastic large cell lymphoma of T-cell phenotype.

H Yaakup1, I Sagap, S A Fadilah.   

Abstract

Primary oesophageal lymphoma is a very rare entity, with fewer than 30 reported cases worldwide. It represents an important cause of dysphagia. Most of the oesophageal lymphomas are diffuse large B-cell type, with only one reported case of anaplastic large cell lymphoma (ALCL) of T-cell phenotype. Primary oesophageal lymphomas that are not associated with an immunocompromised state tend to affect elderly patients. We describe the first case of primary oesophageal Ki (CD30)-positive ALK+ALCL of T-cell phenotype in a 34-year-old immunocompetent woman, who presented with a two-year history of dysphagia. She was treated with chemotherapy and endoscopic oesophageal dilations and stenting, resulting in complete remission of the lymphoma and resolution of the dysphagia. She then underwent autologous peripheral blood haematopoietic stem cell transplantation and remained disease-free two years after the diagnosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18946602

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  7 in total

Review 1.  Primary esophageal CD30-positive ALK-positive anaplastic large cell lymphoma: a case report and literature review.

Authors:  Ning Wu; Liewen Pang; Zhiming Chen; Yiqing Wang; Qinyun Ma; Gang Chen; Ji Chen; Jiechun Huang
Journal:  J Gastrointest Cancer       Date:  2011-03

2.  Primary esophageal non-Hodgkin's lymphoma: demographics, clinical characteristics, histopathologic types, and survival in 179 patients from the SEER program and systematic review of the literature.

Authors:  Andrea Carolina Quiroga-Centeno; Ileana Rocio Bautista-Parada; Luis F Tapias; Sergio Alejandro Gómez-Ochoa
Journal:  Esophagus       Date:  2021-04-20       Impact factor: 4.230

Review 3.  Mechanisms of Acquired Resistance to ALK Inhibitors and the Rationale for Treating ALK-positive Lung Cancer.

Authors:  Hideko Isozaki; Nagio Takigawa; Katsuyuki Kiura
Journal:  Cancers (Basel)       Date:  2015-04-30       Impact factor: 6.639

Review 4.  Primary Esophageal Extranasal NK/T Cell Lymphoma With Biphasic Morphology: A Case Report and Literature Review.

Authors:  Zi-Yin Ye; Qing-Hua Cao; Fang Liu; Xiao-Fang Lu; Shu-Rong Li; Chang-Zhao Li; Shao-Hong Chen
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

5.  ALK-positive anaplastic large cell lymphoma presenting multiple lymphomatous polyposis: A case report and literature review.

Authors:  Makoto Saito; Koh Izumiyama; Reiki Ogasawara; Akio Mori; Takeshi Kondo; Masanori Tanaka; Masanobu Morioka; Kencho Miyashita; Mishie Tanino
Journal:  World J Clin Cases       Date:  2019-08-06       Impact factor: 1.337

6.  Successful treatment of post chemotherapy esophageal cicatricial atresia in a pediatric patient with anaplastic large cell lymphoma through minimally invasive esophagectomy: a case report.

Authors:  Yuto Hozaka; Ken Sasaki; Takuro Nishikawa; Shun Onishi; Masahiro Noda; Yusuke Tsuruda; Yasuto Uchikado; Yoshiaki Kita; Takaaki Arigami; Shinichiro Mori; Kosei Maemura; Satoshi Ieiri; Yoshifumi Kawano; Shoji Natsugoe; Takao Ohtsuka
Journal:  Surg Case Rep       Date:  2021-02-05

7.  PAX-5 positive anaplastic large cell lymphoma presenting by dysphagia; a case report.

Authors:  Negar Azarpira; Akbar Safaie; Ahmad Monabati; Masudd Hosseinzadeh; Sadat Noori; Maryam Moini; Alireza Rahimi; Tahereh Heidari; Marjan Rahsaz
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2017
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.